So it looks like this might be the end of the road for Osprey. Prior to releasing their most recent 4C they went into a trading halt, which then rolled over into voluntary suspension allowing the company "time to complete its consideration of strategic and funding options... including a possible sale of assets.'' A few days later, they had another announcement, this time saying that they're sacking staff beginning immediately. They don't say how many, but presumably it's a lot.
This isn't any surprise, since in their 4C they had receipts of only USD 411,000 during the quarter, and USD 2.6 million cash on hand, but they spent USD 1.7 million just on staff costs alone in the quarter. You feel bad for the everyone who gets sacked, but they must have seen it coming given these numbers.
That announcement finished off with "The company continues to assess next steps and expects to update the market shortly on further developments." It seems the only real hope from here will be a sale of their technology to a big pharma company or a medical products manufacturer.
(Disc: held --- a very, very small quantity. But at least it hasn't gotten any smaller for a few days!)